LIFETECH SCI.DL-00000125
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more
LIFETECH SCI.DL-00000125 (81X) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, LIFETECH SCI.DL-00000125 (81X) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
LIFETECH SCI.DL-00000125 - Net Assets Trend (None–None)
This chart illustrates how LIFETECH SCI.DL-00000125's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for LIFETECH SCI.DL-00000125 (None–None)
The table below shows the annual net assets of LIFETECH SCI.DL-00000125 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to LIFETECH SCI.DL-00000125's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
LIFETECH SCI.DL-00000125 Competitors by Market Cap
The table below lists competitors of LIFETECH SCI.DL-00000125 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hubei Huitian New Materials
SHE:300041
|
$649.09 Million |
|
Suning Commerce Group Co Ltd
SHE:002024
|
$649.12 Million |
|
Temple & Webster Group Ltd
PINK:TPLWF
|
$649.48 Million |
|
Talkspace Inc
NASDAQ:TALK
|
$649.77 Million |
|
Is Yatirim Menkul Degerler AS
IS:ISMEN
|
$648.25 Million |
|
Porch Group Inc
NASDAQ:PRCH
|
$648.25 Million |
|
Seven Bank Ltd
F:0S7
|
$648.12 Million |
|
Newag S.A.
WAR:NWG
|
$647.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LIFETECH SCI.DL-00000125's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares LIFETECH SCI.DL-00000125's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently LIFETECH SCI.DL-00000125 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares LIFETECH SCI.DL-00000125's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LIFETECH SCI.DL-00000125 (81X) | €- | N/A | N/A | $648.48 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |